Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Nutt

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Catechol O-methyltransferase inhibition and the treatment of Parkinson's diseaseJ G Nutt
The Western Journal of Medicine|May 19, 1998
New pharmacological and surgical therapies for Parkinson's diseaseJ G Nutt
Annals of the New York Academy of Sciences|January 1, 1988
Parkinsonism: candidate disorder for implanted pumps?J G Nutt
Annals of Neurology|April 13, 2000
Clinical pharmacology of levodopa-induced dyskinesiaJ G Nutt
Neurology|January 9, 2001
Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patientsJ G Nutt
Parkinsonism & Related Disorders|August 8, 2001
Motor fluctuations and dyskinesia in Parkinson's diseaseJ G Nutt
Annals of Neurology|October 1, 1987
On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamicsJ G Nutt
Advances in Neurology|September 14, 2001
Fluctuations in response to treatment for Parkinson's diseaseJ G Nutt
Current Opinion in Neurology|August 1, 1995
Management of parkinsonism and treatment of associated complicationsJ G Nutt
Advances in Neurology|January 1, 1996
Effects of catechol-O-methyltransferase (COMT) inhibition on the pharmacokinetics of L-DOPAJ G Nutt
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Catechol O-methyltransferase inhibition and the treatment of Parkinson's diseaseJ G Nutt
The Western Journal of Medicine|May 19, 1998
New pharmacological and surgical therapies for Parkinson's diseaseJ G Nutt
Annals of the New York Academy of Sciences|January 1, 1988
Parkinsonism: candidate disorder for implanted pumps?J G Nutt
Annals of Neurology|April 13, 2000
Clinical pharmacology of levodopa-induced dyskinesiaJ G Nutt
Neurology|January 9, 2001
Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patientsJ G Nutt
Parkinsonism & Related Disorders|August 8, 2001
Motor fluctuations and dyskinesia in Parkinson's diseaseJ G Nutt
Annals of Neurology|October 1, 1987
On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamicsJ G Nutt
Advances in Neurology|September 14, 2001
Fluctuations in response to treatment for Parkinson's diseaseJ G Nutt
Current Opinion in Neurology|August 1, 1995
Management of parkinsonism and treatment of associated complicationsJ G Nutt
Advances in Neurology|January 1, 1996
Effects of catechol-O-methyltransferase (COMT) inhibition on the pharmacokinetics of L-DOPAJ G Nutt
Pageof 13